Cure8 news brief
Cure8 news brief
Researchers mapped cell-type gene activity in Crohn’s ileum and found persistent immune-related gene activation in stem cells after inflammation healed, plus macrophage signatures tied to the JAK/STAT pathway. This could help explain recurrence and point to targets for future research.
Researchers and clinicians studying IBD pathogenesis or drug targets; patients and caregivers interested in the biological basis of Crohn’s and how relapse might be driven at the cellular level; researchers using single-cell genomics resources.
This report summarizes a single-cell RNA sequencing study of terminal ileum biopsies from people with Crohn’s disease and healthy controls. The researchers profiled over a million gut cells and created an open dataset called IBDverse.
A key finding described is a persistent “molecular scar” in intestinal stem cells: some immune-related genes remained active even after visible inflammation had healed.
The team also highlighted a macrophage population expressing ITGA4 that appears to signal via the JAK/STAT pathway; the article notes JAK inhibitors are used in IBD and suggests these macrophages could be relevant therapeutic targets.
This is a genomics resource and hypothesis-generating study (Nature Genetics). It does not describe new clinical treatments or outcomes; experimental findings require validation and clinical correlation. The article is a press-style summary republished from the original research.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.